Clinical study of mediation method in the treatment of cough variant asthma in childre

Phase 1

• Conditions: Respiratory diseases

• Registration Number: ITMCTR2000003866
• Lead Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Diagnosed as CVA according to the diagnostic criteria of western medicine;
2. Compliant with TCM syndrome differentiation of children's CVA;
3. Age 5-16 years old, able to cooperate with examination and treatment and follow-up investigation;
4. Obtain the approval of the hospital ethics committee;
5. Obtain the consent of the child and (or) parents, and sign the informed consent form.

Exclusion Criteria

1. Patients with acquired immunodeficiency syndrome and primary immunodeficiency;
2. Congenital heart disease, congenital respiratory malformation and congenital immobility syndrome, gastroesophageal reflux disease;
3. Combined chronic diseases: anemia, Patients with rickets, malnutrition, typical asthma, tuberculosis, and serious primary diseases of the heart, liver, and kidneys;
4. Use glucocorticoids, ß2 adrenergic receptor agonists, leukotriene receptor antagonists, Those with anti-allergic drugs;
5. Those who are allergic to test drugs and their ingredients;
6. Voluntarily accept treatment, observation and follow-up, and have a tendency to disobey promises.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life assessment;Liver and kidney function;Cough symptom score;Allergy indicators;Evaluation of clinical efficacy;Pulmonary function;Blood routine;